WILMINGTON, DE — Incyte (Nasdaq: INCY) announced that it will release its third quarter 2025 financial results before markets open on Tuesday, October 28, 2025. The company will host a conference call and live webcast to discuss the results and provide a business update at 8:00 a.m. Eastern Time the same day.
The earnings release will be available at 7:00 a.m. ET, followed by the investor call an hour later. Participants in the U.S. can dial 877-407-3042 to join the call, while international participants may use 201-389-0864. The conference ID number is 13756261. A replay of the call will remain accessible for thirty days at 877-660-6853 (U.S.) or 201-612-7415 (international), using the same conference ID. The webcast, including presentation slides, can be accessed at Investor.Incyte.com and will be archived for ninety days.
Headquartered in Wilmington, Delaware, Incyte is a global biopharmaceutical company focused on discovering, developing, and commercializing innovative medicines for patients with serious diseases. Its portfolio spans oncology and inflammation and autoimmunity, supported by a growing pipeline and international operations across North America, Europe, and Asia.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.